iPSC-Derived Cardiomyocytes – YBLiCardio

YBLiCardio, our iPSC-derived cardiomyocytes, offer a versatile array of features suitable for a wide range of applications. These cells exhibit electrical activity and rhythmic contractions, closely mimicking the behaviour of mature cardiac cells. They display robust responses to gold-standard tool compounds, making them invaluable for acute and chronic drug testing. YBLiCardio is sensitive to cardiotoxic compounds, such as anthracyclines, TKIs, and hERG-trafficking modulators, underlining their significance in drug safety assessments. Furthermore, they maintain genomic expression patterns akin to adult human cardiac tissue. Flow cytometry analysis confirms their purity, while their viability ensures a strong starting point for experiments and research. With a good seeding efficiency during growth, YBLiCardio combines stability and reliability for long-term studies and investigations, making them a compelling choice in the field of cardiac research and drug discovery